The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions
Abstract
INTRODUCTION: Drug-drug interactions (DDIs) arise in numerous different ways, involving pharmacokinetic or pharmacodynamic mechanisms. Adverse drug reactions are a possible consequence of DDIs and health operators are often unaware of the clinical risks of certain drug combinations. Many papers on drug interactions have been published in recent years, but most of them focused on potential DDIs while few studies have been conducted on actual interactions. AREAS COVERED: This paper reviews the epidemiology of actual DDIs in outpatients as well as in hospital settings and in spontaneous reporting databases. The incidence of actual DDIs is consistently lower than that of potential DDIs. However, the absolute number of patients involved is high, representing a significant proportion of adverse drug reactions. The importance of risk factors such as age, polypharmacy and genetic polymorphisms is also evaluated. The relevance and efficacy of tools for recognizing and preventing DDIs are discussed. EXPERT OPINION: Potential DDIs far outnumber actual drug interactions. The potential for an adverse interaction to occur is often theoretical, and clinically important adverse effects occur only in the presence of specific risk factors. Several studies have shown the efficacy of computers in early detection of DDIs. However, a correct risk-benefit evaluation by the prescribing physician, together with a careful clinical, physiological and biochemical monitoring of patients, is essential. Future directions of drug interaction research include the increasing importance of pharmacogenetics in preventing DDIs and the evaluation of interactions with biological drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002) · JAMA · doi:10.1001/jama.287.3.337 · Cited by 1,845
Mechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
Hohl, C. M., Dankoff, J., Colacone, A., & Afilalo, M. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.119456 · Cited by 477
Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents
Nguyen, J. K., Fouts, M. M., Kotabe, S. E., & Lo, E. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.03.002 · Cited by 265
Cited by
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
Ahmed, S., Zhou, Z., Zhou, J., & Chen, S.-Q. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.03.008 · Cited by 371
Noguchi, Y., Tachi, T., & Teramachi, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab347 · Cited by 285
Van De Sijpe, G., Quintens, C., Walgraeve, K., Van Laer, E., Penny, J., De Vlieger, G., Schrijvers, R., De Munter, P., Foulon, V., Casteels, M., et al. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01783-z · Cited by 54
“More specifically, 5–17% of adverse drug events among inpatients are caused by drug–drug interactions (DDIs) [1, 6].”
BackgroundPolenick, C. A., Stanz, S. D., Leggett, A. N., Maust, D. T., Hodgson, N. A., & Kales, H. C. (2020) · The Gerontologist · doi:10.1093/geront/gny130 · Cited by 37
Designing and evaluating contextualized drug–drug interaction algorithms
Chou, E., Boyce, R. D., Balkan, B., Subbian, V., Romero, A., Hansten, P. D., Horn, J. R., Gephart, S., & Malone, D. C. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab023 · Cited by 34
Metadata
- Authors
- Magro, L., Moretti, U., & Leone, R.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2011-10-25
- Volume
- 11
- Issue
- 1
- Pages
- 83-94
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2010783249
- Cited by
- 287
- References
- 4
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions. https://app.cochat.ai/papers/10.1517/14740338.2012.631910
- The paper
- Magro, L., Moretti, U., & Leone, R. (2012). Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.2012.631910
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.